Prosecution Insights
Last updated: November 04, 2026
Application No. 18/680,149

Deodorizing Composition Including Hydrogen Peroxide and Silver Ions

Non-Final OA §103
Filed
May 31, 2024
Priority
May 31, 2023 — provisional 63/469,971
Examiner
WORSHAM, JESSICA N
Art Unit
1615
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Applied Silver, Inc.
OA Round
1 (Non-Final)
56%
Grant Probability
Moderate
1-2
OA Rounds
6m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 56% of resolved cases
56%
Career Allowance Rate
426 granted / 754 resolved
-3.5% vs TC avg
Strong +56% interview lift
Without
With
+56.4%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
43 currently pending
Career history
810
Total Applications
across all art units

Statute-Specific Performance

§101
1.2%
-38.8% vs TC avg
§103
41.9%
+1.9% vs TC avg
§102
13.4%
-26.6% vs TC avg
§112
25.9%
-14.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 754 resolved cases

Office Action

§103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Detailed Action Response to Restriction Applicants’ election without traverse of Group I (claims 1-14) in the reply filed on 11 August 2026 is acknowledged. Status of Application The instant application was filed 31 May 2023. Claims 1-20 are currently pending. Claims 15-20 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 11 August 2026. Claims 1-14 are examined on the merits within. Claim Rejections – 35 U.S.C. 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1-14 are rejected under 35 U.S.C. 103 as being unpatentable over Joshi (U.S. Patent Application Publication No. 2018/0230413) in view of Joshi (U.S. Patent Application Publication No. 2017/0368220), hereinafter Joshi ‘220, and Dodd et al. (U.S. Patent No. 6,344,218). Joshi teaches a wipe comprising a first chemical element or compound and second chemical element or compound carried by a first substrate. The first and second chemical element or compound are selected from chemically reactive couples structured such that fluid applied to the first substrate is effective to cause a chemical reaction to produce a treatment agent. A workable fluid includes water. The first chemical element or compound and the second chemical element or compound can be Hydrogen Peroxide and Silver Nitrate. See paragraph [0014]. The invention is directed to deodorizing methods. See paragraph [0002]. Hydrogen peroxide is present in amounts of about 2% to about 30%. See paragraph [0133]. Joshi does not teach amounts of silver nitrate, water, fragrance or surfactant. Joshi ‘220 teaches a combination of about 5 to 50% hydrogen peroxide and about 0.05 to 5% silver nitrate. See paragraph [0008]. The invention relates to methods of deodorizing. See paragraph [0002]. Dodd et al. teach aqueous compositions comprising an odor controlling agent and select sanitizing agents. See abstract. Sanitizing actives include antimicrobials, antiseptics, and mixtures thereof. See column 7, lines 40-54. Antimicrobial agents include silver nitrate, hydrogen peroxide, and combinations thereof. See column 8, lines 8-27. The composition comprises about 5 to 70% water. See column 10, lines 31-37. The composition includes 0 to 0.5% perfumes. See column 14, lines 6-14. Surfactants provide a low surface tension to permit the composition to spread readily and uniformly on skin surfaces and other surfaces to improve cleaning. See column 16, lines 55-64. Surfactants are present in amounts of 0 to 20%. See column 19, lines 46-49. It would have been obvious to one of ordinary skill in the art as of the effective filing date of the invention to modify the amounts of hydrogen peroxide, silver ions, and water to achieve the desired deodorizing and sanitizing effects because Joshi teaches an effective amount of hydrogen peroxide as 2 to 30% and Joshi ‘220 teaches 5 to 50% hydrogen peroxide and about 0.05 to 5% silver nitrate resulting in a ratio of about 1:1. One would have been motivated, with a reasonable expectation of success, to provide a product with the desired amount of both deodorizing and disinfecting properties. It would have been obvious to one of ordinary skill in the art as of the effective filing date of the invention to add up to 0.5% perfumes and/or 0 to 3% surfactant because Dodd et al. teach addition of both of these components in the claimed amounts to formulations that provide both odor control and sanitization. One would have been motivated, with a reasonable expectations of success, to provide a pleasant smell, as well as lower the surface tension of the composition to improve cleaning. It would have been well within the purview of the skilled artisan to modify the pH of the composition dependent on the surface to be treated. It would have been obvious to one of ordinary skill in the art as of the effective filing date of the invention to substitute one type of perfume/fragrance for another to yield predictable results, i.e., bioidentical. Conclusion 5. No claims are allowed at this time. 6. Any inquiry concerning this communication or earlier communications from the examiner should be directed to JESSICA WORSHAM whose telephone number is (571)270-7434. The examiner can normally be reached Monday-Friday (8-5). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Robert Wax can be reached at 571-272-0623. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JESSICA WORSHAM/Primary Examiner, Art Unit 1615
Read full office action

Prosecution Timeline

May 31, 2024
Application Filed
Oct 20, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12778981
LIPID COMPOSITION CONTAINING MICRONUTRIENTS FOR THE PREVENTION AND/OR TREATMENT OF METABOLIC DISEASES
5y 6m to grant Granted Nov 03, 2026
Patent 12778915
N-PALMITOYL-ETHANOLAMIDE FOR USE IN THE PREVENTION OF COLORECTAL CARCINOMA
4y 7m to grant Granted Nov 03, 2026
Patent 12778896
A METHOD FOR TREATING CANCER WITH AN ORAL DOSAGE FORM OF AN FGFR4 INHIBITOR
3y 11m to grant Granted Nov 03, 2026
Patent 12778956
PROCESS FOR IMPROVING FLUIDITY OF PALBOCICLIB ISETHIONATE AND COMPOSITION
3y 7m to grant Granted Nov 03, 2026
Patent 12773381
COSMETIC COMPOSITION COMPRISING THIOPYRIDINONE COMPOUNDS, REDUCING AGENT AND ARGININE
2y 10m to grant Granted Oct 27, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
56%
Grant Probability
99%
With Interview (+56.4%)
2y 11m (~6m remaining)
Median Time to Grant
Low
PTA Risk
Based on 754 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month